Jaguar Health adopts 1-year rights plan after receiving acquisition interest

Jaguar Health, Inc.

Board adopted limited-duration rights plan on Feb 26, 2025; expires Feb 26, 2026.
Rights trigger at 20% beneficial ownership of voting stock; holders can buy shares at $4.50 for twice the market value.
Jaguar received indication of interest to acquire the company; plan aims to discourage open-market accumulation without a premium.
First proof-of-concept IIT results for crofelemer in SBS-IF and MVID expected Q2 2025; FDA meeting on breast cancer subgroup results also Q2.
Record date for rights dividend is March 10, 2025.

item 1.01 item 3.03 item 5.03 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Jaguar Health, Inc.: Adopted a Certificate of Designation for Series K Junior Participating Preferred Stock in connection with a Rights Agreement (effective 2025-02-27).

Change: charter amendment
Effective: 2025-02-27

Exact text from the filing

In connection with the adoption of the Rights Agreement, the Company has adopted a Certificate of Designation of Series K Junior Participating Preferred Stock (the “Certificate of Designation”). The Certificate of Designation was filed with the Secretary of State of the State of Delaware on February 27, 2025.

View on SEC.gov

23 governance changes filed in the last 30 days. Browse all governance changes →

Jaguar Health, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-25-028403

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.